Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease

被引：0
|
作者：
Sharon Rikin
Stephanie Deccy
Chenshu Zhang
Jill Crandall
Yuting Deng
Ladan Golestaneh
机构：
[1] Montefiore Medical Center and Albert Einstein College of Medicine,Division of General Internal Medicine
[2] Montefiore Medical Center and Albert Einstein College of Medicine,undefined
来源：
Journal of General Internal Medicine | 2023年 / 38卷
关键词：
chronic kidney disease; evidence-based medicine; diabetes mellitus; sodium-glucose cotransporter-2 inhibitor; renin and angiotensin system inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1599 / 1605
页数：6
相关论文
共 50 条
  • [21] The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice
    Li, Zi
    Murakoshi, Maki
    Ichikawa, Saki
    Koshida, Takeo
    Adachi, Eri
    Suzuki, Chigure
    Ueda, Seiji
    Gohda, Tomohito
    Suzuki, Yusuke
    FEBS OPEN BIO, 2020, 10 (12): : 2761 - 2770
  • [22] ADHERENCE OF CHRONIC KIDNEY DISEASE PATIENTS TO SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR (SGLT2I) DURING RAMADAN PERIOD
    Lee, Fei Yee
    Tiong, Kung Ung
    Rosdi, Hajar Ahmad
    Liew, Hui Nee
    Kwong, Gabriel Kin Wei
    Ismail, Siti Hafizah Mohammad
    Yakob, Suryati
    NEPHROLOGY, 2024, 29 : 91 - 91
  • [23] Sodium-Glucose Cotransporter-2 Inhibitor Immediately Decreases Serum Uric Acid Levels in Type 2 Diabetic Patients
    Ohashi, Naro
    Aoki, Taro
    Matsuyama, Takashi
    Ishigaki, Sayaka
    Isobe, Shinsuke
    Fujikura, Tomoyuki
    Hashimoto, Takuya
    Tsuriya, Daisuke
    Morita, Hiroshi
    Kato, Akihiko
    Yasuda, Hideo
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [24] COMPARING THE OUTCOMES EXPERIENCED IN SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR KIDNEY OUTCOME TRIALS TO A CANADIAN CHRONIC KIDNEY DISEASE COHORT
    Yi, Tae Won
    Atiquzzaman, Mohammad
    Zheng, Yuyan
    Smyth, Brendan
    Jardine, Meg
    Levin, Adeera
    NEPHROLOGY, 2022, 27 : 34 - 35
  • [25] Solution is not simple; sodium-glucose cotransporter-2 inhibitor use in Conn syndrome
    Soyaltin, Utku
    BLOOD PRESSURE MONITORING, 2024, 29 (04) : 195 - 197
  • [26] Association of sodium-glucose cotransporter-2 inhibitor with regression of coronary plaque burden
    Zhang, T.
    Du, Y.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [27] Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition
    Kang, Dong Yoon
    Kim, Hyunah
    Ko, SooJeong
    Kim, HyungMin
    Shinn, Jiwon
    Kang, Min-Gyu
    Byeon, Sun-Ju
    Choi, Jeong-Hee
    Shin, Soo-Yong
    Kim, Hun-Sung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (07)
  • [28] Association of sodium-glucose cotransporter-2 inhibitor with regression of coronary plaque burden
    Zhang, T.
    Du, Y.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [29] Baseline Characteristics Associated With Sodium-Glucose Cotransporter Inhibitor Prescriptions in Type 2 Diabetic Patients in Jazan, Saudi Arabia
    Somaili, Mohammed
    Oraibi, Omar
    Mohrag, Mostafa
    Hommadi, Abdelrahman
    Moafa, Esam
    Kulaybi, Abdulrahman
    Shobayli, Sahar
    Moafa, Razan
    Mhgfory, Ghadah
    Jaafari, Afaf
    Shami, Ayman
    Majrashi, Khalid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [30] Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
    Alicic, Radica Z.
    Neumiller, Joshua J.
    Johnson, Emily J.
    Dieter, Brad
    Tuttle, Katherine R.
    DIABETES, 2019, 68 (02) : 248 - 257
12345